In Vitro and In Vivo Evaluation of Commercially Available Fibrin Gel as a Carrier of Alendronate for Bone Tissue Engineering

Alendronate (ALN) is a bisphosphonate drug that is widely used for the treatment of osteoporosis. Furthermore, local delivery of ALN has the potential to improve the bone regeneration. This study was designed to investigate an ALN-containing fibrin (fibrin/ALN) gel and evaluate the effect of this ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Beom Su, Shkembi, Feride, Lee, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292194/
https://www.ncbi.nlm.nih.gov/pubmed/28210623
http://dx.doi.org/10.1155/2017/6434169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292194/
https://www.ncbi.nlm.nih.gov/pubmed/28210623
http://dx.doi.org/10.1155/2017/6434169

Ejemplares similares